NPM1 and acute myeloid leukemia: Other leading mutated genes recurrently identified in various AML cohorts [11, 30, 31], such as FLT3, NPM1, and TP53, exhibited no significant EA when assessed using the Pan‐tissue clock or CausAge predictions.